Invention Grant
- Patent Title: Inhibitors of cholesterol ester transfer protein
-
Application No.: US14981088Application Date: 2015-12-28
-
Publication No.: US09708277B2Publication Date: 2017-07-18
- Inventor: Roger D. Tung
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: CONCERT PHARMACEUTICALS, INC.
- Current Assignee: CONCERT PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Lexington
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K31/427
- IPC: A61K31/427 ; C07D263/20 ; A61K31/40 ; A61K31/421
Abstract:
The invention relates to novel oxazolidinones their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering cholesterol ester transfer protein inhibitors.
Public/Granted literature
- US20160115138A1 Inhibitors of Cholesterol Ester Transfer Protein Public/Granted day:2016-04-28
Information query
IPC分类:
